Bell Investment Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $869 | Sell |
75
-97
| -56% | -$1.12K | ﹤0.01% | 1633 |
|
|
2025
Q1 | $1.5K | Sell |
172
-50
| -23% | -$437 | ﹤0.01% | 1414 |
|
|
2024
Q4 | $3.19K | Buy |
222
+110
| +98% | +$1.58K | ﹤0.01% | 1145 |
|
|
2024
Q3 | $2.53K | Buy |
112
+76
| +211% | +$1.72K | ﹤0.01% | 1251 |
|
|
2024
Q2 | $701 | Sell |
36
-6
| -14% | -$117 | ﹤0.01% | 1706 |
|
|
2024
Q1 | $1.58K | Sell |
42
-24
| -36% | -$901 | ﹤0.01% | 1445 |
|
|
2023
Q4 | $3.69K | Sell |
66
-38
| -37% | -$2.13K | ﹤0.01% | 1042 |
|
|
2023
Q3 | $4.29K | Sell |
104
-19
| -15% | -$784 | ﹤0.01% | 888 |
|
|
2023
Q2 | $6.87K | Buy |
123
+9
| +8% | +$503 | ﹤0.01% | 663 |
|
|
2023
Q1 | $6.36K | Hold |
114
| – | – | ﹤0.01% | 671 |
|
|
2022
Q4 | $4.15K | Buy |
114
+62
| +119% | +$2.26K | ﹤0.01% | 905 |
|
|
2022
Q3 | $1K | Buy |
52
+34
| +189% | +$654 | ﹤0.01% | 1608 |
|
|
2022
Q2 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 1634 |
|
|
2021
Q4 | $1K | Sell |
10
-33
| -77% | -$3.3K | ﹤0.01% | 1641 |
|
|
2021
Q3 | $6K | Buy |
+43
| New | +$6K | ﹤0.01% | 670 |
|